LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 51

Search options

  1. Article ; Online: INCIDENCE OF COINFECTION IN PATIENTS WITH COVID-19

    Aleman, Valeria Demeneghi / Garnett Carbajal, Jose Alfonso / Alvarez Velazquez, Frida Andrea / Mohiuddin, Mariya / Varon, Daryelle / Surani, Salim / Varon, Joseph

    Chest

    2020  Volume 158, Issue 4, Page(s) A343

    Keywords Critical Care and Intensive Care Medicine ; Pulmonary and Respiratory Medicine ; Cardiology and Cardiovascular Medicine ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ZDB-ID 1032552-9
    ISSN 1931-3543 ; 0012-3692
    ISSN (online) 1931-3543
    ISSN 0012-3692
    DOI 10.1016/j.chest.2020.08.340
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article: Incidence of Coinfection in Patients with Covid-19

    Aleman, V. D. / Garnett Carbajal, J. A. / Alvarez Velazquez, F. A. / Mohiuddin, M. / Varon, D. / Surani, S. / Varon, J.

    Chest

    Abstract: ... locations 4,195 (9 6%) patients had positive results for COVID-19 The total positive results for RPP was 1 ... A positive test for respiratory pathogens does not exclude the coinfection with COVID-19 or vice versa Age ... ON: October 18-21, 2020 PURPOSE: A recent surge of novel COVID-19 has diverted the focus from other microbial ...

    Abstract SESSION TITLE: Chest Infections Posters SESSION TYPE: Original Investigation Posters PRESENTED ON: October 18-21, 2020 PURPOSE: A recent surge of novel COVID-19 has diverted the focus from other microbial organisms as the etiology of respiratory illness Causal agents for respiratory infections have been linked to different risk factors and clinical presentations The propose of this study is to analyze the incidence of coinfection and the factors that determine it METHODS: Respiratory Pathogen Panel (RPP), targeting 21 different organisms, was performed to randomized individuals undergoing testing for COVID-19 RT-PCR at four testing locations in Houston, Texas between March 2020 to May 2020 Tested subjects were inquired about their demographic information, positive exposure to COVID-19, current symptoms, and comorbidities RESULTS: A total of 10,853 RPP tests were performed alongside COVID-19 RT-PCR (43,443) tests completed across the 4 locations 4,195 (9 6%) patients had positive results for COVID-19 The total positive results for RPP was 1,276 (11%) Both RT-PCR and RPP were positive in 78 cases (0 7%), with 12 different organisms identified as the causal agents in these cases The most common being Rhinovirus in 37 1% (n=29), followed by Staphylococcus Aureus in 33 3% (n=26) and Haemophilus influenzae 21 7%, (n=17) Other organisms included S pneumonia, K pneumonia, Influenza A, Influenza B, parainfluenza virus, metapneumovirus, adenovirus, enterovirus, and other strains of coronavirus 7 cases were identified to have 2 positive organisms in RPP, in addition to being positive to COVID-19 5 of which included rhinovirus and 4 of them had H influenzae Age was found to have a great influence on the incidence of different organisms of these concomitant infections From the 11 cases that were 18 years old or younger, 45 4% had S aureus as the causal agent and 27 2% were positive for H influenzae Cases among individuals >65 years old were positive only for rhinovirus CONCLUSIONS: A positive test for respiratory pathogens does not exclude the coinfection with COVID-19 or vice versa Age seemed to be the factor with the highest influence in determining the causal agent of these concomitant infections CLINICAL IMPLICATIONS: Workup for respiratory infections should include testing for COVID-19, given that a positive RPP in a symptomatic or asymptomatic patient does not exclude concomitant infection with the novel coronavirus Age range should also be considered as a determinant factor influencing causal agent of coinfection DISCLOSURES: No relevant relationships by Frida Andrea Alvarez Velazquez, source=Web Response No relevant relationships by Valeria Demeneghi Aleman, source=Web Response No relevant relationships by JOSE ALFONSO GARNETT CARBAJAL, source=Web Response No relevant relationships by Mariya Mohiuddin, source=Web Response No relevant relationships by Salim Surani, source=Web Response No relevant relationships by Daryelle Varon, source=Web Response No relevant relationships by Joseph Varon, source=Web Response
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #866528
    Database COVID19

    Kategorien

  3. Article: Incidence of Bacterial and Fungal Secondary Infections in COVID-19 Patients Admitted to the ICU.

    Alshrefy, Afnan J / Alwohaibi, Rawaa N / Alhazzaa, Shahad A / Almaimoni, Reema A / AlMusailet, Latifah I / AlQahtani, Shaya Y / Alshahrani, Mohammed S

    International journal of general medicine

    2022  Volume 15, Page(s) 7475–7485

    Abstract: ... and fungal secondary infections among ICU patients with COVID-19.: Methods: A retrospective chart ... All adult patients aged ≥18 admitted in the ICU for ≥48 hours with positive COVID-19 reverse transcription ... of 314 critically ill patients, 133 (42.4%) developed secondary infections. The incidence of secondary ...

    Abstract Purpose: Secondary infections have been observed among coronavirus disease 2019 (COVID-19) patients, especially in the intensive care unit (ICU) setting, which is associated with worse clinical outcomes. The current study aimed to investigate the incidence, common pathogens, and outcome of bacterial and fungal secondary infections among ICU patients with COVID-19.
    Methods: A retrospective chart review of all patients admitted to the ICU at King Fahd Hospital of the University in Saudi Arabia. All adult patients aged ≥18 admitted in the ICU for ≥48 hours with positive COVID-19 reverse transcription-polymerase chain reaction test during the period between March 2020 till September 2021 were included.
    Results: Out of 314 critically ill patients, 133 (42.4%) developed secondary infections. The incidence of secondary bacterial infection was 32.5% with
    Conclusion: Bacterial and fungal secondary infections are common among COVID-19 patients admitted to the ICU with a predominance of gram-negative bacteria and
    Language English
    Publishing date 2022-09-24
    Publishing country New Zealand
    Document type Journal Article
    ZDB-ID 2452220-X
    ISSN 1178-7074
    ISSN 1178-7074
    DOI 10.2147/IJGM.S382687
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors.

    Ripa, Marco / Galli, Laura / Poli, Andrea / Oltolini, Chiara / Spagnuolo, Vincenzo / Mastrangelo, Andrea / Muccini, Camilla / Monti, Giacomo / De Luca, Giacomo / Landoni, Giovanni / Dagna, Lorenzo / Clementi, Massimo / Rovere Querini, Patrizia / Ciceri, Fabio / Tresoldi, Moreno / Lazzarin, Adriano / Zangrillo, Alberto / Scarpellini, Paolo / Castagna, Antonella

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

    2020  Volume 27, Issue 3, Page(s) 451–457

    Abstract: ... lymphocyte count (≤0.7 versus >0.7 per 10: Conclusions: Patients hospitalized with COVID-19 had a high incidence ... of secondary infections in patients with coronavirus disease 2019 (COVID-19).: Methods: This was a cohort study ... of patients hospitalized with COVID-19 at IRCCS San Raffaele Hospital between 25th February and 6th April 2020 ...

    Abstract Objectives: The aim of our study was to describe the incidence and predictive factors of secondary infections in patients with coronavirus disease 2019 (COVID-19).
    Methods: This was a cohort study of patients hospitalized with COVID-19 at IRCCS San Raffaele Hospital between 25th February and 6th April 2020 (NCT04318366). We considered secondary bloodstream infections (BSIs) or possible lower respiratory tract infections (pLRTIs) occurring 48 hours after hospital admission until death or discharge. We calculated multivariable Fine-Gray models to assess factors associated with risk of secondary infections.
    Results: Among 731 patients, a secondary infection was diagnosed in 68 patients (9.3%); 58/731 patients (7.9%) had at least one BSI and 22/731 patients (3.0%) at least one pLRTI. The overall 28-day cumulative incidence was 16.4% (95%CI 12.4-21.0%). Most of the BSIs were due to Gram-positive pathogens (76/106 isolates, 71.7%), specifically coagulase-negative staphylococci (53/76, 69.7%), while among Gram-negatives (23/106, 21.7%) Acinetobacter baumanii (7/23, 30.4%) and Escherichia coli (5/23, 21.7%) predominated. pLRTIs were caused mainly by Gram-negative pathogens (14/26, 53.8%). Eleven patients were diagnosed with putative invasive aspergillosis. At multivariable analysis, factors associated with secondary infections were low baseline lymphocyte count (≤0.7 versus >0.7 per 10
    Conclusions: Patients hospitalized with COVID-19 had a high incidence of secondary infections. At multivariable analysis, early need for ICU, respiratory failure, and severe lymphopenia were identified as risk factors for secondary infections.
    MeSH term(s) Aged ; COVID-19/epidemiology ; Cohort Studies ; Coinfection/epidemiology ; Coinfection/microbiology ; Female ; Hospitalization/statistics & numerical data ; Humans ; Incidence ; Italy/epidemiology ; Male ; Middle Aged ; Respiratory Tract Infections/epidemiology ; Respiratory Tract Infections/microbiology ; Risk Factors ; SARS-CoV-2 ; Sepsis/epidemiology ; Sepsis/etiology ; Sepsis/microbiology
    Keywords covid19
    Language English
    Publishing date 2020-10-24
    Publishing country England
    Document type Journal Article
    ZDB-ID 1328418-6
    ISSN 1469-0691 ; 1470-9465 ; 1198-743X
    ISSN (online) 1469-0691
    ISSN 1470-9465 ; 1198-743X
    DOI 10.1016/j.cmi.2020.10.021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Low incidence of co-infection, but high incidence of ICU-acquired infections in critically ill patients with COVID-19.

    Soriano, María Cruz / Vaquero, Concepción / Ortiz-Fernández, Almudena / Caballero, Alvaro / Blandino-Ortiz, Aaron / de Pablo, Raúl

    The Journal of infection

    2020  Volume 82, Issue 2, Page(s) e20–e21

    MeSH term(s) COVID-19 ; Coinfection/epidemiology ; Critical Illness ; Humans ; Incidence ; Intensive Care Units ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-09-19
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 424417-5
    ISSN 1532-2742 ; 0163-4453
    ISSN (online) 1532-2742
    ISSN 0163-4453
    DOI 10.1016/j.jinf.2020.09.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Incidence of co-infections and superinfections in hospitalised patients with COVID-19

    Garcia Vidal, Carolina / Sanjuan, Gemma / Moreno García, Estela / Puerta Alcalde, Pedro / Garcia-Pouton, Nicole / Chumbita, Mariana / Fernandez-Pittol, Mariana / Pitart, Cristina / Inciarte, Alexy / Bodro, Marta / Morata, Laura / Ambrosioni, Juan / Grafia, Ignacio / Meira, Fernanda / Macaya, Irene / Cardozo Espinola, Celia / Casals Pascual, Climent / Tellez, Adrian / Castro Rebollo, Pedro /
    Marco Reverté, Francesc / García Alcaide, Felipe / Mensa Pueyo, Josep / Martínez, José Antonio (Martínez Martínez) / Soriano Viladomiu, Alex / COVID-19 Researchers Group

    a retrospective cohort study

    2020  

    Abstract: ... Co-infection at COVID-19 diagnosis is uncommon. Few patients developed superinfections during hospitalization ... occurring in hospitalized patients with coronavirus disease 2019 (COVID-19). Methods: We performed ... from electronic health records. Results: Of a total of 989 consecutive patients with COVID-19, 72 (7.2%) had 88 ...

    Abstract Objectives: To describe the burden, epidemiology and outcomes of co-infections and superinfections occurring in hospitalized patients with coronavirus disease 2019 (COVID-19). Methods: We performed an observational cohort study of all consecutive patients admitted for ≥48 hours to the Hospital Clinic of Barcelona for COVID-19 (28 February to 22 April 2020) who were discharged or dead. We describe demographic, epidemiologic, laboratory and microbiologic results, as well as outcome data retrieved from electronic health records. Results: Of a total of 989 consecutive patients with COVID-19, 72 (7.2%) had 88 other microbiologically confirmed infections: 74 were bacterial, seven fungal and seven viral. Community-acquired co-infection at COVID-19 diagnosis was uncommon (31/989, 3.1%) and mainly caused by Streptococcus pneumoniae and Staphylococcus aureus. A total of 51 hospital-acquired bacterial superinfections, mostly caused by Pseudomonas aeruginosa and Escherichia coli, were diagnosed in 43 patients (4.7%), with a mean (SD) time from hospital admission to superinfection diagnosis of 10.6 (6.6) days. Overall mortality was 9.8% (97/989). Patients with community-acquired co-infections and hospital-acquired superinfections had worse outcomes. Conclusions: Co-infection at COVID-19 diagnosis is uncommon. Few patients developed superinfections during hospitalization. These findings are different compared to those of other viral pandemics. As it relates to hospitalized patients with COVID-19, such findings could prove essential in defining the role of empiric antimicrobial therapy or stewardship strategies.
    Keywords COVID-19 ; Infeccions ; Infections ; covid19
    Subject code 610
    Language English
    Publishing date 2020-10-30T18:06:11Z
    Publisher European Society of Clinical Microbiology and Infectious Diseases
    Publishing country es
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.

    Garcia-Vidal, Carolina / Sanjuan, Gemma / Moreno-García, Estela / Puerta-Alcalde, Pedro / Garcia-Pouton, Nicole / Chumbita, Mariana / Fernandez-Pittol, Mariana / Pitart, Cristina / Inciarte, Alexy / Bodro, Marta / Morata, Laura / Ambrosioni, Juan / Grafia, Ignacio / Meira, Fernanda / Macaya, Irene / Cardozo, Celia / Casals, Climent / Tellez, Adrian / Castro, Pedro /
    Marco, Francesc / García, Felipe / Mensa, Josep / Martínez, José Antonio / Soriano, Alex

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

    2020  Volume 27, Issue 1, Page(s) 83–88

    Abstract: ... Co-infection at COVID-19 diagnosis is uncommon. Few patients developed superinfections during hospitalization ... occurring in hospitalized patients with coronavirus disease 2019 (COVID-19).: Methods: We performed ... from electronic health records.: Results: Of a total of 989 consecutive patients with COVID-19, 72 (7.2%) had 88 ...

    Abstract Objectives: To describe the burden, epidemiology and outcomes of co-infections and superinfections occurring in hospitalized patients with coronavirus disease 2019 (COVID-19).
    Methods: We performed an observational cohort study of all consecutive patients admitted for ≥48 hours to the Hospital Clinic of Barcelona for COVID-19 (28 February to 22 April 2020) who were discharged or dead. We describe demographic, epidemiologic, laboratory and microbiologic results, as well as outcome data retrieved from electronic health records.
    Results: Of a total of 989 consecutive patients with COVID-19, 72 (7.2%) had 88 other microbiologically confirmed infections: 74 were bacterial, seven fungal and seven viral. Community-acquired co-infection at COVID-19 diagnosis was uncommon (31/989, 3.1%) and mainly caused by Streptococcus pneumoniae and Staphylococcus aureus. A total of 51 hospital-acquired bacterial superinfections, mostly caused by Pseudomonas aeruginosa and Escherichia coli, were diagnosed in 43 patients (4.7%), with a mean (SD) time from hospital admission to superinfection diagnosis of 10.6 (6.6) days. Overall mortality was 9.8% (97/989). Patients with community-acquired co-infections and hospital-acquired superinfections had worse outcomes.
    Conclusions: Co-infection at COVID-19 diagnosis is uncommon. Few patients developed superinfections during hospitalization. These findings are different compared to those of other viral pandemics. As it relates to hospitalized patients with COVID-19, such findings could prove essential in defining the role of empiric antimicrobial therapy or stewardship strategies.
    MeSH term(s) Aged ; Anti-Bacterial Agents/therapeutic use ; Bacterial Infections/epidemiology ; Bacterial Infections/microbiology ; Bacterial Infections/mortality ; Bacterial Infections/therapy ; Bacterial Typing Techniques ; Blood Culture/methods ; COVID-19/epidemiology ; COVID-19/mortality ; COVID-19/therapy ; COVID-19/virology ; Coinfection ; Community-Acquired Infections ; Cross Infection/epidemiology ; Cross Infection/microbiology ; Cross Infection/mortality ; Cross Infection/therapy ; Female ; Hospitalization ; Hospitals ; Humans ; Incidence ; Male ; Middle Aged ; Mycoses/epidemiology ; Mycoses/microbiology ; Mycoses/mortality ; Mycoses/therapy ; Retrospective Studies ; SARS-CoV-2/pathogenicity ; Spain/epidemiology ; Sputum/microbiology ; Superinfection/epidemiology ; Superinfection/mortality ; Superinfection/therapy ; Superinfection/virology ; Survival Analysis ; Virus Diseases/epidemiology ; Virus Diseases/mortality ; Virus Diseases/therapy ; Virus Diseases/virology
    Chemical Substances Anti-Bacterial Agents
    Keywords covid19
    Language English
    Publishing date 2020-07-31
    Publishing country England
    Document type Journal Article ; Observational Study
    ZDB-ID 1328418-6
    ISSN 1469-0691 ; 1470-9465 ; 1198-743X
    ISSN (online) 1469-0691
    ISSN 1470-9465 ; 1198-743X
    DOI 10.1016/j.cmi.2020.07.041
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Incidence of co-infections and superinfections in hospitalized patients with COVID-19

    Garcia-Vidal, Carolina / Sanjuan, Gemma / Moreno-García, Estela / Puerta-Alcalde, Pedro / Garcia-Pouton, Nicole / Chumbita, Mariana / Fernandez-Pittol, Mariana / Pitart, Cristina / Inciarte, Alexy / Bodro, Marta / Morata, Laura / Ambrosioni, Juan / Grafia, Ignacio / Meira, Fernanda / Macaya, Irene / Cardozo, Celia / Casals, Climent / Tellez, Adrian / Castro, Pedro /
    Marco, Francesc / García, Felipe / Mensa, Josep / Martínez, José Antonio / Soriano, Alex / Rico, Verónica / Hernández-Meneses, Marta / Agüero, Daiana / Torres, Berta / González, Ana / de la Mora, Lorena / Rojas, Jhon / Linares, Laura / Fidalgo, Berta / Rodriguez, Natalia / Nicolas, David / Albiach, Laia / Muñoz, José / Almuedo, Alex / Camprubí, Daniel / Angeles Marcos, Ma / Cilloniz, Catia / Fernández, Sara / Nicolas, Jose M. / Torres, Antoni

    Clinical Microbiology and Infection ; ISSN 1198-743X

    a retrospective cohort study

    2020  

    Keywords Microbiology (medical) ; Infectious Diseases ; General Medicine ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    DOI 10.1016/j.cmi.2020.07.041
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: Incidence and Characteristics of Co-infection and Secondary Infection in Patients with COVID-19

    Guo, Yingyi / Qu, Jiuxin / Cheng, Lingling / Li, Xiaohe / Liu, Ningjing / Li, Tungngai / Jiang, Ying / Wan, Qiao / Zhuo, Chuyue / Xiao, Shunian / Liu, Baomo / Chen, Yan / Fu, lin / Chen, Zhixu / Ma, Mingcong / Zhuo, Chao / Zhong, Nanshan

    bioRxiv

    Abstract: ... and secondary infection in COVID-19 patients, mainly focusing on Streptococcus pneumoniae ... Patients with confirmed COVID-19 were rarely co-infected with Streptococcus pneumoniae or other pathogens ... Objective: The etiology and epidemiology of co-infection and secondary infection in COVID-19 ...

    Abstract Objective: The etiology and epidemiology of co-infection and secondary infection in COVID-19 patients remain unknown. The study aims to investigate the occurrence and characteristics of co-infection and secondary infection in COVID-19 patients, mainly focusing on Streptococcus pneumoniae co-infections. Methods: This study was a prospective, observational cohort study of the inpatients diagnosed with COVID-19 in two designated hospitals in south China enrolled between Jan 11 and Feb 22, 2020. The urine specimen was collected on admission and applied for pneumococcal urinary antigen tests (PUATs). Demographic, clinical and microbiological data of patients were recorded simultaneously. Result: A total of 146 patients with a confirm diagnosis of COVID-19 at the median age of 50.0 years (IQR 36.0-61.0) were enrolled, in which, 16 (11.0%) were classified as severe cases and 130 (89.0%) as non-severe cases. Of the enrolled patients, only 3 (2.1%) were considered to present the co-infection, in which 1 was co-infected with S.pneumoniae, 1 with B. Ovatus infection and the other one with Influenza A virus infection. Secondary infection occurred in 16 patients, with S. maltophilia as the most commonly isolated pathogen (43.8%), followed by P. aeruginosa (25.0%), E. aerogenes (25.0%), C. parapsilosis (25.0%) and A. fumigates (18.8%). Conclusion: Patients with confirmed COVID-19 were rarely co-infected with Streptococcus pneumoniae or other pathogens, indicating that the application of antibiotics against CAP on admission may not be necessary in the treatment of COVID-19 cases.
    Keywords covid19
    Language English
    Publishing date 2021-01-06
    Publisher Cold Spring Harbor Laboratory
    Document type Article ; Online
    DOI 10.1101/2021.01.06.425542
    Database COVID19

    Kategorien

  10. Article: Low incidence of co-infection, but high incidence of ICU-acquired infections in critically ill patients with COVID-19

    Soriano, M. C. / Vaquero, C. / Ortiz-Fernández, A. / Caballero, A. / Blandino-Ortiz, A. / Pablo, R.

    J Infect

    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #779273
    Database COVID19

    Kategorien

To top